A clinical trial of the Ebola vaccine by Merck and NewLink has been halted for all 59 volunteers in Geneva a week early "as a measure of precaution" after four patients complained of joint pains in hands and feet, the University of Geneva Hospital said on Thursday.
"They are all fine and being monitored regularly by the medical team leading the study," it said in a statement.
The human safety trials are due to resume on Jan. 5 in up to 15 volunteers after checks to ensure that the joint pain symptoms were "benign and temporary", the hospital said.
In order news:
The condition of the Italian doctor who contracted Ebola in Sierra Leone has improved further, Rome's Spallanzani Institute for infectious diseases said on Thursday.
The 50-year-old who was working for the medical aid charity Emergency in the West African nation does not have a fever, is breathing spontaneously and does not need ventilator support, the hospital said. He is also interacting positively with medical staff and answering questions, doctors added. On Wednesday the hospital announced that the doctor could breathe autonomously but stressed that it was not possible to say whether he was out of danger.
Click here to "like" the 4119ja Facebook page, to get updates directly on your Facebook timeline. Subscribe to our BBM Channel (C00379595D or search for "411 9ja") to get live updates on published post. Please drop your comments below
No comments:
Post a Comment